These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 14768852)

  • 1. MR imaging of the musculoskeletal soft tissue mass: is heterogeneity a sign of malignancy?
    Pang KK; Hughes T
    J Chin Med Assoc; 2003 Nov; 66(11):655-61. PubMed ID: 14768852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating benign and malignant soft tissue masses by magnetic resonance imaging: role of tissue component analysis.
    Chen CK; Wu HT; Chiou HJ; Wei CJ; Yen CH; Chang CY; Chen WM
    J Chin Med Assoc; 2009 Apr; 72(4):194-201. PubMed ID: 19372075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soft tissue masses with "cyst-like" appearance on MR imaging: Distinction of benign and malignant lesions.
    Harish S; Lee JC; Ahmad M; Saifuddin A
    Eur Radiol; 2006 Dec; 16(12):2652-60. PubMed ID: 16670867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of MR findings in predicting the nature of the soft tissue lesions: benign, malignant or undetermined lesion?
    Soler R; Castro JM; Rodríguez E
    Comput Med Imaging Graph; 1996; 20(3):163-9. PubMed ID: 8930469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft-tissue masses: diagnosis using MR imaging.
    Kransdorf MJ; Jelinek JS; Moser RP; Utz JA; Brower AC; Hudson TM; Berrey BH
    AJR Am J Roentgenol; 1989 Sep; 153(3):541-7. PubMed ID: 2763953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of musculoskeletal lesions: comparison of three fat-saturation pulse sequences.
    Pui MH; Goh PS; Choo HF; Fok EC
    Australas Radiol; 1997 May; 41(2):99-102. PubMed ID: 9153802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour and tumour-like conditions of the soft tissue: magnetic resonance imaging features differentiating benign from malignant masses.
    Hermann G; Abdelwahab IF; Miller TT; Klein MJ; Lewis MM
    Br J Radiol; 1992 Jan; 65(769):14-20. PubMed ID: 1336692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR imaging differentiation of soft-tissue hemangiomas from malignant soft-tissue masses.
    Teo EL; Strouse PJ; Hernandez RJ
    AJR Am J Roentgenol; 2000 Jun; 174(6):1623-8. PubMed ID: 10845496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MR imaging of primary bone and soft tissue tumors].
    Uchida M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jun; 50(6):637-48. PubMed ID: 2235314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign and malignant soft tissue mass: magnetic resonance imaging criteria for discrimination.
    Kalayanarooj S
    J Med Assoc Thai; 2008 Jan; 91(1):74-81. PubMed ID: 18386548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions.
    Berquist TH; Ehman RL; King BF; Hodgman CG; Ilstrup DM
    AJR Am J Roentgenol; 1990 Dec; 155(6):1251-5. PubMed ID: 2122675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osseous invasion by soft-tissue sarcoma: assessment with MR imaging.
    Elias DA; White LM; Simpson DJ; Kandel RA; Tomlinson G; Bell RS; Wunder JS
    Radiology; 2003 Oct; 229(1):145-52. PubMed ID: 14519874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review.
    De Beuckeleer LH; De Schepper AM; Vandevenne JE; Bloem JL; Davies AM; Oudkerk M; Hauben E; Van Marck E; Somville J; Vanel D; Steinbach LS; Guinebretière JM; Hogendoorn PC; Mooi WJ; Verstraete K; Zaloudek C; Jones H
    Skeletal Radiol; 2000 Apr; 29(4):187-95. PubMed ID: 10855466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Musculoskeletal lymphoma: MRI of bone or soft tissue presentations.
    Carroll G; Breidahl W; Robbins P
    J Med Imaging Radiat Oncol; 2013 Dec; 57(6):663-73. PubMed ID: 24283554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions.
    Moulton JS; Blebea JS; Dunco DM; Braley SE; Bisset GS; Emery KH
    AJR Am J Roentgenol; 1995 May; 164(5):1191-9. PubMed ID: 7717231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: Report of the Radiology Diagnostic Oncology Group.
    Panicek DM; Gatsonis C; Rosenthal DI; Seeger LL; Huvos AG; Moore SG; Caudry DJ; Palmer WE; McNeil BJ
    Radiology; 1997 Jan; 202(1):237-46. PubMed ID: 8988217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of 3T magnetic resonance dynamic contrast-enhanced and diffusion-weighted imaging in differential diagnosis of musculoskeletal tumors].
    Qi ZH; Li CF; Ma XX; Yang H; Jiang BD; Zhang K; Yu DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Apr; 34(2):138-45. PubMed ID: 22776599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From the archives of the AFIP: benign musculoskeletal lipomatous lesions.
    Murphey MD; Carroll JF; Flemming DJ; Pope TL; Gannon FH; Kransdorf MJ
    Radiographics; 2004; 24(5):1433-66. PubMed ID: 15371618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are signal intensity and homogeneity useful parameters for distinguishing between benign and malignant soft tissue masses on MR images? Objective evaluation by means of texture analysis.
    Mayerhoefer ME; Breitenseher M; Amann G; Dominkus M
    Magn Reson Imaging; 2008 Nov; 26(9):1316-22. PubMed ID: 18448302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle edema in musculoskeletal tumors: MR imaging characteristics and clinical significance.
    Hanna SL; Fletcher BD; Parham DM; Bugg MF
    J Magn Reson Imaging; 1991; 1(4):441-9. PubMed ID: 1790366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.